Study reveals privacy risks in female health apps

FHS
May 15, 2024
12:08 pm

Apps designed for female health monitoring are exposing users to unnecessary privacy and safety risks through their poor data handling practices, according to new research from UCL and King’s College London.

New analysis confirms canagliflozin’s cardiovascular and kidney benefits in older adults

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their

October 27, 2024

Faster Hormonal Control With Personalized Acromegaly Treatment Approach

A personalized treatment protocol was more effective for management of acromegaly — also known as gigantism — than the usual trial-and-error approach, the prospective ACROFAST

July 10, 2024

BD tells customers not to use Cardinal’s Monoject syringes with Alaris pumps

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.